First Long Island Investors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $25.7M | Sell |
118,369
-1,332
| -1% | -$295K | 2.09% | 19 |
|
|
2025
Q4 | $27.4M | Buy |
119,701
+430
| +0.4% | +$98K | 2.01% | 17 |
|
|
2025
Q3 | $27.6M | Sell |
119,271
-225
| -0.2% | -$45.8K | 2.05% | 18 |
|
|
2025
Q2 | $22.2M | Sell |
119,496
-1,345
| -1% | -$250K | 1.74% | 21 |
|
|
2025
Q1 | $25.3M | Sell |
120,841
-18,927
| -14% | -$3.68M | 2.09% | 18 |
|
|
2024
Q4 | $24.8M | Buy |
139,768
+72
| +0.1% | +$13.2K | 1.97% | 19 |
|
|
2024
Q3 | $27.6M | Sell |
139,696
-879
| -0.6% | -$164K | 2.17% | 14 |
|
|
2024
Q2 | $24.1M | Sell |
140,575
-2,748
| -2% | -$455K | 2.04% | 17 |
|
|
2024
Q1 | $26.1M | Sell |
143,323
-3,076
| -2% | -$530K | 2.17% | 17 |
|
|
2023
Q4 | $22.7M | Sell |
146,399
-2,717
| -2% | -$396K | 2.01% | 21 |
|
|
2023
Q3 | $22.2M | Buy |
149,116
+547
| +0.4% | +$80.3K | 2.15% | 16 |
|
|
2023
Q2 | $20M | Buy |
148,569
+1,017
| +0.7% | +$149K | 1.92% | 22 |
|
|
2023
Q1 | $23.5M | Sell |
147,552
-22,181
| -13% | -$3.39M | 2.39% | 15 |
|
|
2022
Q4 | $27.4M | Sell |
169,733
-2,556
| -1% | -$392K | 2.88% | 11 |
|
|
2022
Q3 | $23.1M | Sell |
172,289
-1,406
| -0.8% | -$202K | 2.57% | 14 |
|
|
2022
Q2 | $26.6M | Sell |
173,695
-27,505
| -14% | -$4.2M | 2.77% | 12 |
|
|
2022
Q1 | $32.6M | Sell |
201,200
-26,057
| -11% | -$3.79M | 2.77% | 11 |
|
|
2021
Q4 | $30.8M | Buy |
227,257
+11,220
| +5% | +$1.33M | 2.42% | 14 |
|
|
2021
Q3 | $23.3M | Buy |
216,037
+7,817
| +4% | +$893K | 2% | 22 |
|
|
2021
Q2 | $23.5M | Sell |
208,220
-8,267
| -4% | -$931K | 2.01% | 21 |
|
|
2021
Q1 | $23.4M | Sell |
216,487
-3,616
| -2% | -$387K | 2.08% | 18 |
|
|
2020
Q4 | $23.6M | Buy |
220,103
+16,790
| +8% | +$1.61M | 2.2% | 19 |
|
|
2020
Q3 | $17.8M | Buy |
203,313
+15,724
| +8% | +$1.48M | 1.84% | 21 |
|
|
2020
Q2 | $18.4M | Sell |
187,589
-1,703
| -0.9% | -$150K | 2.09% | 19 |
|
|
2020
Q1 | $14.4M | Buy |
189,292
+58,077
| +44% | +$4.95M | 1.96% | 20 |
|
|
2019
Q4 | $11.6M | Buy |
131,215
+14,356
| +12% | +$1.19M | 1.3% | 37 |
|
|
2019
Q3 | $8.85M | Sell |
116,859
-60
| -0.1% | -$4.11K | 1.08% | 45 |
|
|
2019
Q2 | $8.5M | Buy |
116,919
+1,360
| +1% | +$107K | 1.06% | 41 |
|
|
2019
Q1 | $9.31M | Sell |
115,559
-34,727
| -23% | -$2.84M | 1.2% | 39 |
|
|
2018
Q4 | $13.9M | Sell |
150,286
-80
| -0.1% | -$7.04K | 2.06% | 21 |
|
|
2018
Q3 | $14.2M | Buy |
150,366
+5,195
| +4% | +$493K | 1.84% | 24 |
|
|
2018
Q2 | $13.4M | Sell |
145,171
-13,041
| -8% | -$1.27M | 1.92% | 23 |
|
|
2018
Q1 | $15M | Sell |
158,212
-31,392
| -17% | -$3.45M | 2.07% | 20 |
|
|
2017
Q4 | $18.3M | Sell |
189,604
-3,327
| -2% | -$314K | 2.49% | 11 |
|
|
2017
Q3 | $17.1M | Buy |
192,931
+17,497
| +10% | +$1.33M | 2.49% | 10 |
|
|
2017
Q2 | $12.7M | Buy |
175,434
+3,576
| +2% | +$240K | 1.97% | 20 |
|
|
2017
Q1 | $11.2M | Buy |
171,858
+201
| +0.1% | +$12.6K | 1.86% | 25 |
|
|
2016
Q4 | $10.7M | Buy |
171,657
+8,225
| +5% | +$502K | 1.87% | 25 |
|
|
2016
Q3 | $10.3M | Sell |
163,432
-807
| -0.5% | -$52.2K | 1.87% | 24 |
|
|
2016
Q2 | $10.2M | Buy |
164,239
+5,035
| +3% | +$307K | 1.89% | 28 |
|
|
2016
Q1 | $9.09M | Buy |
159,204
+559
| +0.4% | +$31.2K | 1.73% | 36 |
|
|
2015
Q4 | $9.4M | Buy |
+158,645
| New | +$9.14M | 1.78% | 26 |
|
Other funds holding ABBV
VCM
VPM
First Long Island Investors's ABBV Position: Q1 2026 in Review
First Long Island Investors reduced its AbbVie (ABBV) stake by 1.1% in Q1 2026, selling an estimated $295K and leaving 118,369 shares worth $25.7M. The position accounts for 2.09% of the portfolio, ranked #19.
First Long Island Investors first reported a position in ABBV in Q4 2015 and has held it in 42 quarters since. The position peaked at $32.6M in Q1 2022. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- First Long Island Investors held 118,369 shares of AbbVie worth $25.7M as of Q1 2026.
- First Long Island Investors sold 1,332 AbbVie shares in Q1 2026, an estimated $295K.
- AbbVie made up 2.09% of First Long Island Investors's portfolio in Q1 2026, its #19 holding.
- First Long Island Investors first reported a position in AbbVie in Q4 2015 and has held it in 42 quarters since.
- First Long Island Investors's AbbVie position peaked at $32.6M in Q1 2022.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on First Long Island Investors's 13F filing for Q1 2026, filed 15 May 2026.